...All right. Thank you, and good morning, everyone. And once again, welcome to the 40th Annual and unfortunately second time Virtual at JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst. And it's my pleasure to introduce our next company, Biogen and CEO, Michel Vounatsos. Please note that following this presentation, we will move right into the Q&A where you can send in your own questions via the little blue ask a question button on the conference portal, and I'll do my best to work them into the conversation. So Michel, thank you very much for being with us here today. Let me hand things over to you. Michel Vounatsos ...